Pediatric Neurology
Volume 26, Issue 3 , Pages 228-230, March 2002

Benign intracranial hypertension: atypical presentation of Miller Fisher syndrome?

  • Leena D Mewasingh, MD

      Affiliations

    • Department of Neurology, Hôpital Universitaire des Enfants Reine Fabiola, 1020 Brussels, Belgium
  • ,
  • Tayeb Sékhara, MD

      Affiliations

    • Department of Neurology, Hôpital Universitaire des Enfants Reine Fabiola, 1020 Brussels, Belgium
  • ,
  • Bernard Dachy, MD

      Affiliations

    • Department of Clinical Neurophysiology, Hôpital Brugmann, 1020 Brussels, Belgium
  • ,
  • Maurice C Djeunang, MD

      Affiliations

    • Department of Neurology, Hôpital Universitaire des Enfants Reine Fabiola, 1020 Brussels, Belgium
  • ,
  • Bernard Dan, MD

      Affiliations

    • Corresponding Author InformationCommunications should be addressed to: Prof. Dan; Department of Neurology; Hôpital Universitaire des Enfants Reine Fabiola; 15 Avenue JJ Crocq; 1020 Brussels, Belgium
    • Department of Neurology, Hôpital Universitaire des Enfants Reine Fabiola, 1020 Brussels, Belgium

Received 7 June 2001; accepted 4 September 2001.

Abstract 

Acute ocular paresis, nausea, vomiting, and headaches associated with high intracranial pressure without obvious intracranial pathology are typical features of benign intracranial hypertension. We describe two young children whose presentation, initially suggestive of idiopathic or benign intracranial hypertension, evolved to comprise ophthalmoplegia, ataxia, and areflexia. This triad characterizes Miller Fisher syndrome, a clinical variant of Guillain-Barré syndrome that occurs rarely among children. In both patients, this diagnosis was supported by the clinical course and neurophysiologic findings. Plasma serology was positive for Campylobacter jejuni and anti-GQ1b antibodies in one patient and for antimyelin antibodies in the other. This report of two children with Miller Fisher syndrome presenting with intracranial hypertension adds to the findings for a similar patient treated previously, which raises the question concerning the possible role or contribution of benign intracranial hypertension in Miller Fisher syndrome.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0887-8994(01)00362-9

Pediatric Neurology
Volume 26, Issue 3 , Pages 228-230, March 2002